CIK: 1260573 - Address: C/O Graphite Bio, Inc., 201 Haskins Way, Suite 210, South San Francisco, CA 94080
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11101138590036
P%wins100100100100100
S%ret118-112816187
S%wins88503825132540

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/18/20 16:29
12/17/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticKarsen Perry AMADM.d1,63818.450895D
12/18/20 16:29
12/17/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticKarsen Perry AMADS.d-4,75453.550-89-955D
6/7/17 18:18
6/5/17
OMEDOncomed Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsKarsen Perry ACADP353.46010New10D
2/2/17 17:03
2/1/17
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKarsen Perry AMADP8016.00235New5D-10113859
12/18/15 16:21
12/17/15
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d00.003381268D40-1-4-9-7002111-2-8-106
5/15/15 16:29
5/13/15
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d1,49148.9433308566D77527-11-37111-413-3-13
5/15/15 16:29
5/13/13
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-5,425115.0033-47-4266D77527-11-37111-413-3-13
5/4/15 19:15
4/30/15
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d00.0033111683D90495-7-14-5-4-3-2341914-4
3/3/15 16:24
3/1/15
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d00.003381278D13350277-120-210-3-35-11
2/13/15 17:07
2/11/15
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d1,04737.5233286174D134443173-7-2-2074-112-12
2/13/15 17:07
2/11/15
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-3,351120.1233-28-2774D134443173-7-2-2074-112-12
1/2/15 16:01
12/30/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d69429.7533236659D1853224205-3-5-1-115156
1/2/15 16:01
12/30/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-2,185113.3733-19-2559D1853224205-3-5-1-115156
11/14/14 16:13
11/12/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d1,05532.90333214155D1894446201342-103711113
11/14/14 16:13
11/12/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-4,227107.2333-39-4255D1894446201342-103711113
8/5/14 16:14
8/4/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d1,30828.16334629562D156191818211-1-1010233551
8/5/14 16:14
8/4/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-3,42387.5533-39-3962D156191818211-1-1010233551
5/5/14 18:16
5/1/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d69459.5033127427D10224-3-32820-1-15174448
5/5/14 18:16
5/1/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-1,750146.7833-12-3027D10224-3-32820-1-15174448
3/5/14 16:20
3/3/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS-383159.0533-2-828D12153160-4110-4-3-10-51747
12/31/13 16:26
12/27/13
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d00.003385223D148117421012-1412-3-9-13534
11/5/13 16:02
11/1/13
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d00.00331011219D1371062463-3-50-4-260-440
8/2/13 17:46
8/2/13
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaM.d5,31245.023311814D151114502531111040-4-53317
8/2/13 17:46
8/2/13
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-13,626146.5033-93-8714D151114502531111040-4-53317

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact